Memic Innovative Surgery

About Memic Innovative Surgery

Momentis Surgical develops the Anovo™ Surgical System, a miniaturized, two-armed robotic platform for minimally-invasive procedures, initially focused on robotic-assisted vaginal surgery. Its key differentiator is enabling complex maneuvers within the body via human-like articulation, reducing invasiveness & OR costs compared to traditional systems. Having secured $130M in funding & 16 US patents, Momentis received De Novo FDA clearance in 2021 & recently expanded into general surgery with 510(k) clearance. Led by experienced robotics veterans like former MAKO Surgical CEO Dr. Maurice Ferré, Momentis aims to broaden access to advanced surgical robotics.

Key Products & Services

Anovo™ Surgical System, Anovo

Industry Sectors